Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Dieude

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Rheumatology|June 19, 2024
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung diseaseRathnam K Venkat, Keigo Hayashi, Pierre-Antoine Juge, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2026
Diagnostic accuracy of <sup>18</sup>F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP)Chloé Quéré, Valérie Devauchelle-Pensec, Philippe Thuillier, et al.
Joint Bone Spine|February 22, 2021
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)Camille Villon, Laure Orgeolet, Anne-Marie Roguedas, et al.
Rheumatology (Oxford, England)|November 24, 2020
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparisonJean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, et al.
Plos One|December 16, 2020
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort studyRaphael Borie, Laurent Savale, Antoine Dossier, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.
Annals of the Rheumatic Diseases|March 19, 2017
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosisChikashi Terao, Takahisa Kawaguchi, Philippe Dieude, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Rheumatology|June 19, 2024
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung diseaseRathnam K Venkat, Keigo Hayashi, Pierre-Antoine Juge, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2026
Diagnostic accuracy of <sup>18</sup>F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP)Chloé Quéré, Valérie Devauchelle-Pensec, Philippe Thuillier, et al.
Joint Bone Spine|February 22, 2021
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)Camille Villon, Laure Orgeolet, Anne-Marie Roguedas, et al.
Rheumatology (Oxford, England)|November 24, 2020
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparisonJean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, et al.
Plos One|December 16, 2020
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort studyRaphael Borie, Laurent Savale, Antoine Dossier, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosisEguzkine Ochoa, José-Ezequiel Martin, Shervin Assasi, et al.
Annals of the Rheumatic Diseases|March 19, 2017
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosisChikashi Terao, Takahisa Kawaguchi, Philippe Dieude, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 5